PTK2 and neoplasm: These data indicated that SY-707 had very potent anti-tumor activities in T47D xenograft models and sensitizedin vivo efficacy of paclitaxel in T47D and 4T1 xenograft models, which revealed a direct relationship among SY-707 levels in tumor tissues, tumor growth inhibition rate, and the inhibition of phosphorylation of FAK.